Carbohydrate mixtures

Details Carbohydrate mixtures Carbohydrate mixtures

2007-01-05

2009-10-13

Vu, Jake M. (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

C514S023000, C514S053000, C514S054000

Reexamination Certificate

active

07601364

ABSTRACT:
A carbohydrate mixture for dietetic foods and pharmaceuticals containing several carbohydrates is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate components A and B, which remain undigested in the gastrointestinal tract and enter the large intestine without being resorbed. Component A comprises at least one monosaccharide, at least one oligosaccharide (disaccharide to hexasaccharide), or a mixture thereof. Component B comprises a polysaccharide or a mixture of two or more polysaccharides. Component A constitutes 5 to 95 wt-% and Component B constitutes 5 to 95 wt-% of the sum of the Components; and at least 80 wt-% of the carbohydrates/saccharides of Components A and B have a prebiotic effect. The inventive carbohydrate mixture exhibits not only a nutritive effect, but also stimulates health-promoting microorganisms present in the natural flora of the large intestine.

REFERENCES:
patent: 5629040 (1997-05-01), Takemori et al.
patent: 5733579 (1998-03-01), Wolf et al.
patent: 5744134 (1998-04-01), Paul
patent: 5776887 (1998-07-01), Wibert et al.
patent: 5792754 (1998-08-01), Green et al.
patent: 5840361 (1998-11-01), Theuer et al.
patent: 6576251 (2003-06-01), Stahl et al.
patent: 1997/28718 (1997-07-01), None
patent: 0382355 (1990-08-01), None
patent: 0 511 761 (1992-11-01), None
patent: 0307 523 (1993-03-01), None
patent: 0593774 (1994-04-01), None
patent: 0 692 252 (1996-01-01), None
patent: 0 705 539 (1996-04-01), None
patent: 0 756 828 (1997-02-01), None
patent: 0 958 825 (1999-11-01), None
patent: 1305071 (1973-01-01), None
patent: 2-286058 (1990-11-01), None
patent: 9-065855 (1997-03-01), None
patent: 10-175867 (1998-06-01), None
patent: WO 95/26646 (1995-10-01), None
patent: WO 96 13271 (1996-05-01), None
patent: WO 97/02829 (1997-01-01), None
patent: WO 97/34615 (1997-09-01), None
patent: WO 98 26787 (1998-06-01), None
patent: WO 98/31241 (1998-07-01), None
Crittenden et al (Production, properties and applications of food-grade oligosaccharides. Trends in Food Science & Technologies, vol. 7, Nov. 1996. pp. 353-361).
S. S. Cho et al., “Complex Carbohydrates in Foods”, Marcel Dekker Inc., N. Y., 1999.
J. H. Cummings, “Gastrointestinal Effects of Food Carbodhydrate1-3”,Am J Clin Nutr, Apr. 1995; Suppl. 4 61 (suppl): pp. 938-945.
T. Kohmoto et al., “Effect of Isomalto-oligosaccharides on Human Fecal Flora”,Bifidobacteria microflora, vol. 7(2), pp. 61-69, 1988.
Masaki Ito et al., “Influence of Galactooligosaccharides on the Human Fecal Microflora”,J. Nutr. Sci . VItaminol, 39, 635-640, 1993.
Masaki Ito et al., “Effects of Transgalactosylated Disaccharides on the Human Intestinal Microflora nd Their Metabolism”,J. Nutr. Sci. Vitaminol., 39, 279-288, 1993.
M. Roberfroid, “Dietary Fiber, Inulin, and Oligofructose: a review comparing their physiological effects”,Critical Reviews in Food Science and Nutricion, 33(2): 103-148, 1993.
G. R. Gibson et al., “Dietary Modulation of the Human Colonic Mlcrobiota: Introducing the Concept of Prebiotics”,American Institute of Nutrition, 0022-3166/1995, pp. 1401-1412.
G. R. Gibson et al., “Bifidogenic properties of different types of fructo-oligosaccharides”,Food Microbiology, 1994, 11, pp. 491-498.
RAFTILOSE® P95 Product Sheet Release: May 1995.
RAFTILINE® ST Product Sheet Release: May 1995.
RAFTILINE® HP Product Sheet Release: May 1995.
K. Yazawa et al., “Search for Sugar Sources for Selective Increase of Bifidobacteria”,Bifidobacteria microflora, vol. 1(1), pp. 39-44, 1982.
RAFTIMIX® 10 Product Sheet Release: May 1995.
Listing of sales of RAFTIMIX® 10 to clients i.a. iin period Sep. 13, 1996 to May 19, 1998, (1998).
Manufacture protocol with composition of RAFTIMIX® 10 1995.
Analysis of RAFTIMIX@10; RAFTIMIX® ST and RAFTILOSE® P95, (1995).
R. Hartemink “Non-digestible oligosaccharides: healthy food for the colon?”Wageningen, The Netherlands, 1997, p. 130-131.
E. Meleghi et al., XXI International Dairy Congress; brief communications “New baby food milk products”, (1982).
R. Tanaka et al., “Effects of Administration of TOS and Bifodobacterium breve 4006 on the Human fecal flora”,Bifidobacteria microflora, vol. 2(1), 17-24, 1983.
S. Salimen et al., “Functional food science and gastrointestinal physiology and function”,British Journal of Nutrition, 1998, 80, Suppl. 1, S147-S171.
G. Gibson et al., “Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics”,American Institute of Nutrition, pp. 1401-1412, 1995.
Y. Bouhnik et al., “Administration of Transgalacto-Oligosaccharides Increases Fecal Bifiobacteria and Modifies Colonic Fermentation Metabolism in Healthy Humans”,American Society for Nutritional Sciences, pp. 444-448, 1997.
M. Ito et al., “Effects of Administration of Galactooligosaccharides on the Human Faecal Microflora, Stool Weight and Abdominal Sensation”,Microbial ecology in health and disease, vol. 3, pp. 285-292, 1990.
R. G. Crittenden et al., “Production, properties and applications of food-grade oligosaccharides”,Trends in Food Science&Technologies, vol. 7, Nov. 1996, pp. 353-361.
G. R. Gibson et al., “Selective stimulation of bifidobacteria in the Human Colon by Oligofructose and Inulin”,Gastroenterology1995, 108, pp. 975-982.
Haastrecht, “Oligosaccharides: Promising Performers in New Product Development,”IFI, No. 1, 1995, pp. 23-27.
Frisomum, Analysis Chart and Brochure, 1998.
Ito, et al., “Influence of Lactose on Faecal Microflora in Lactose Maldigestors,”Microbial Ecology in Health and Disease, vol. 6, 1993, pp. 73-76.
Hertzler, et al., “Colonic Adaptation to Daily Lactose Feeding in Lactose-Maldigesters Reduces Lactose-Intolerance,”Am. J. Clin. Nutr., 1996, pp. 232-236.
Mizota, et al., “Lactulose as a Sugar with Physiological Significance,”Bulletin IDF, No. 212, Trends in Whey Utilization, 1987, Chapter 11.
Bernhart, et al, “Lactulose in Modified Milk Products for Infant Nutrition,”J. Dairy Sci., 1956, pp. 399-400.
Dombo, et al., “Production Health Benefits and Applications of Galacto-oligosaccharides,” Yalpani M. ed.,New Technologies for Healthy Foods and Neutraceuticals, ATL Press, Shewsbury, MA, 1997, pp. 143-156.
Jiang, et al., “In Vitro Lactose Fermentation by Human Colonic Bacteria is Modified bylactobacillusAcidophilus Supplementation,”American Society for Nutritional Sciences, 1997, pp. 1489-1495.
RAFTILINE HP Product Sheet, May 1995.
Rotimi, et al, “The Development of the Bacterial Flora in Normal Neonates,” 1981, pp. 51-61.
Rubaltelli, et al., “Intestinal Flora in Breast- and Bottle-fed Infants,” 1998, pp. 186-190.
Roberfroid, et al., “Health Benefits of Non-Digestible Oligosaccharides,” 1997.
Craig, et al., “Polydextrose as Soluble Fiber: Physiological and Analytical Aspects,” 1998, pp. 370-376.
Terada, et al., “Effect of Lactosucrose on Fecal Flora and Fecal Putrefactive Products of Cats,” 1993.
Mitsuoka, “Intestinal Flora and Human Health,”Asa Pacific J. Clin. Nutr., vol. 15, 1996, pp. 2-8.
Van Loo, et al., “On the Presence of Inulin and Oligofructose as Natural Ingredients in the Western Diet,”Critical Reviews in Food Science and Nutrition, vol. 35, No. 6, 1995, pp. 525-552.

Affiliated with

Also associated with

Rating

Carbohydrate mixtures does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carbohydrate mixtures, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbohydrate mixtures will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4141442